Pharma Industry Insights: Articles, Blogs, Whitepapers & Videos

Global pharmaceutical markets have reached unprecedented scale. With nearly $1.6 trillion in annual revenue, the industry continues to draw companies toward new geographies and growth opportunities. Yet companies entering new geographies often meet a sharper commercial reality: large markets do not always translate into strong returns. Canada shows why market intelligence can matter more than market size.

The Asia-Pacific (APAC) pharmaceutical market, already worth over USD 330 billion in 2024, is entering a new phase of maturity.

The U.S. over-the-counter (OTC) pharmaceutical market is expanding, but not without complexity. Valued at USD 42.4 billion in 2024, it is projected to grow at around 4.8 per cent CAGR through 2034, reflecting steady but margin-tightened growth.

How does a pharma company stay ahead while serving global health needs? By making sustainability, ethics, and governance a core priority.

Everyone sees the product launch. Few see the decisions that made it possible.

The game-changer for sustained growth

Enters S&P yearbook in 1st year of participation

The pharmaceutical industry is evolving rapidly, with increasing regulatory demands, complex drug formulations, and the rise of biologics challenging traditional manufacturing methods. <br> How can companies stay ahead while ensuring efficiency, quality, and compliance? <br><br> This white paper delves into Quality by Design (QbD) and Design of Experiments (DoE)—two transformative methodologies that are revolutionising drug development. <br><br> Learn how top pharmaceutical companies like Strides Pharma leverage these approaches to enhance product quality, reduce risks, optimise processes, and streamline regulatory compliance. <br><br> Get insights on: <br> ✔️ QbD’s shift from reactive testing to built-in quality <br> ✔️ DoE’s role in faster, smarter drug formulation <br> ✔️ A real-world case study on arthritis medication development <br>

Set to skyrocket from $367.1 billion in 2023 to $628 billion by 2032, the generic drug market is experiencing a boom! What's fueling this rapid expansion? A mix of factors: patent expirations, a rise in chronic diseases, and increased research investments.

The pharmaceutical industry is facing an alarming trend: a dramatic increase in drug recalls. In 2022 alone, defective pharmaceutical units hit a five-year high, with January 2023 marking a significant spike in recalls– over 11.88 million units impacted due to critical deviations from Good Manufacturing Practices (GMP).

How can pharmaceutical companies successfully launch across multiple markets in an environment of escalating regulatory, pricing, and operational complexity?<br> What is preventing broader access—and what must change to improve global launch performance?<br> Read on to explore the drivers behind this gap and the strategies that can help organizations expand their market reach more effectively.

Patient centricity isn't a slogan—it's the guiding purpose behind every aspect of our supply chain strategy, ensuring that patients receive the medications they need, precisely when they need them.

On average, pharmaceutical companies face 71 cyberattacks per year, with each successful breach costing approximately $5.2 million.

In this blog, we explore the critical analytical attributes and testing processes that companies like Strides Pharma must implement during the research and development stages to ensure compliance with regulations and optimise product quality.

Intranasal drug delivery is evolving from a simple convenience into a strategic route with broader therapeutic potential. But delivering a drug through the nose is not as straightforward as it seems. It demands precise coordination between formulation, device, and biology. This article breaks down what it really takes to develop reliable, scalable nasal spray products.

A tablet is often judged by its final form. In development, however, its success is decided much earlier: in the behaviour of the API, the choice of excipients, the stability profile, the dissolution pathway, and the way the formulation performs at scale. Each decision shapes whether the product can remain safe, effective, manufacturable, and market-ready. That is why formulation development is a scientific journey that must be built carefully, tested rigorously, and never rushed.

What happens when a formulation that performs flawlessly in a 5-litre lab mixer is scaled up to a 500-litre production vessel—and <br>why is this delicate transition one of the most critical phases in pharmaceutical development that demands closer attention?

In recent years, nitrosamine impurities have emerged as one of the most significant quality and safety challenges facing the global pharmaceutical industry.

Unlocking new frontiers in pharmaceutical innovation

Take a closer look inside SEML facility, located in Bengaluru, India. Strides Pharma’s TGA A1 certified advanced manufacturing facility specializing in oral solid dosage forms. From precision granulation to high-speed compression and encapsulation, SEML facility delivers high-quality tablets and hard gelatin capsules with a strong focus on safety, compliance, and global standards. Explore how science meets precision at every stage — ensuring every dose is effective, consistent, and trusted. To know more visit - www.synergice.co

Step into the heart of pharmaceutical excellence with an immersive virtual tour of our state-of-the-art KRSG facility in Bangalore. Witness cutting-edge technology, world-class manufacturing processes, and a commitment to innovation and quality that defines Strides Pharma.

Every medication’s journey from lab to patient involves rigorous checks to ensure it’s as safe and effective as possible. At Strides Pharma, our Extractables and Leachables (E&L) testing is a crucial step in that journey. By analyzing every packaging component and material with advanced techniques like Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Inductively Coupled Plasma Mass Spectrometry (ICP-MS), we confirm that packaging materials do not interact negatively with the product, preserving the integrity, efficacy, and shelf life of medicines before they reach the patient. This level of testing does more than meet compliance standards—it enhances product stability, extends shelf life, and ultimately protects patient health. For us, quality isn't just a requirement; it's our promise. To learn more, visit www.synergice.co

CPHI Milan 2024 was a remarkable platform for meaningful collaborations, insightful discussions, and showcasing our commitment to innovation and sustainability. Across three days, we explored the future of pharma, highlighted our diverse portfolio, and engaged in impactful conversations that set the stage for continued growth. ​ ​ Thank you to everyone who contributed to the success of this event. Together, we are shaping the future of healthcare and driving progress in the pharmaceutical industry. ​

One global company. Many regional strategies.​ At Strides Pharma, every market gets a portfolio built for its needs, its patients, and its realities.​ That’s how we stay agile, everywhere we operate.​ ​ Learn more at www.synergice.co

Strides looks back on a rewarding experience at CPHI Barcelona 2023, where they engaged with industry leaders and advanced their global presence.

Ensuring precision at every step – from compression to coating, our advanced technology and rigorous quality checks guarantee the highest standards for every tablet we produce. Watch how we perfect each tablet!

At KRSG, we prioritize precision and cleanliness in our powder processing. Our fully automated system ensures zero manual handling, maintaining consistency and eliminating contamination risks at every stage.​​ From mixing to filling and packaging, we consistently deliver superior-quality powder medications, including PEG and Macrogol products.​​

It’s not just about what you make.​ It’s about how you make it, who you make it with and why it matters.​ Watch how sustainability runs through everything we do at Strides Pharma, from energy use to​ human rights.​

Successful pharma partnerships go beyond contracts; they’re built on trust, consistent support and impactful results. Over the years, we’ve had the opportunity of working alongside some of the most respected pharmaceutical companies across the globe. What makes these collaborations successful? A shared commitment to quality, trust, and a collective vision for better healthcare. Watch the video to hear from our global partners and discover what makes Strides Pharma a trusted name in pharmaceutical partnerships.

Reflecting on Day 2 at CPHI Milan 2024, we’re inspired by the momentum and meaningful connections that are helping to shape the future of pharma. Each exchange of valuable insights on pharma innovations and exploration of new opportunities has elevated our plans for growth and progress. Thank you to everyone who connected with us—we’re excited to build on the knowledge shared at CPHI Milan as we continue advancing the future of pharma together.

At Strides, our Quality System Review (QSR) process is the backbone of our commitment to continuous improvement and compliance. Through rigrous & consistent site-level reviews, corporate oversight, and collaborative forums, we ensure that our operations not only meet but exceed industry standards. Discover how QSRs drive our excellence. Learn more at: www.synergice.co

Reflecting on Day 3 at CPHI Milan 2024, from advancing healthcare solutions to exploring sustainable practices, the discussions we had are paving the way for impactful progress. A big thank you to everyone who joined us in exploring the future of Pharma and innovation. The conversations we initiated are only the start, and we look forward to seeing how they will drive meaningful partnerships and contribute to the continued growth of the Pharma industry!

We are excited to reveal Synergice’s new look! With a steadfast commitment to making quality pharmaceuticals accessible across the globe, we have continuously forged strong partnerships and delivered exceptional value to our clients. As we begin this exciting new chapter, we look forward to deepening our relationships and unlocking even greater possibilities together. Join us in our mission to make healthier lives accessible to every community we serve. Together, we will 𝗠𝗮𝗸𝗲 𝗠𝗼𝗿𝗲 𝗣𝗼𝘀𝘀𝗶𝗯𝗹𝗲. Visit our website to learn more: www.synergice.co

We rank among the world’s leading producers of soft gelatin capsules manufacturing around 2 billion SGC units annually. Our manufacturing techniques are shaped by the principles of ‘Quality by Design’ and ‘Design of Experiments’, enabling us to craft a wide array of formulations in different shapes and sizes. We are dedicated to continuous improvement through our technology-driven efforts to enhance bioavailability, minimize side effects, and employ cutting-edge inspection systems. With a team of over 100 highly experienced scientists, we prioritize delivering top-grade soft gel products. Connect with us today www.synergice.co to explore promising opportunities in partnership

Strides Pharma has a proven history of excellence and an in-depth understanding of the global pharmaceutical landscape. With synergICE, a B2B Strides Pharma initiative, we are poised to be your strategic partner in achieving sustained success. If you're a pharmaceutical company seeking high-quality generics, we possess the expertise and resources to meet your needs. Our unwavering commitment to quality, research, and technological advancement sets us apart in the ever-evolving pharmaceutical industry. ​ ​ Let's collaborate to uncover new opportunities, surmount challenges, and create a meaningful impact in the pharmaceutical industry.​ Visit: www.synergice.co to know more!

Immerse yourself in a fully interactive 360° virtual tour of our world-class KRSG facility in Bangalore. Explore every corner of this cutting-edge pharmaceutical hub, where innovation, precision, and quality converge. Witness our advanced manufacturing processes, sustainable practices, and the seamless integration of technology that drives excellence in everything we do.

Looking back at CPHI Milan 2024, we are proud of the outcomes and impactful conversations that took place. From meaningful collaborations to showcasing our diverse portfolio, the event set the stage for exciting advancements in Pharma. Thank you to everyone who made it a success—we're eager to continue driving innovation and growth as we move forward!

2024 has been an extraordinary year for us, marked by milestones in innovation, sustainability, and global expansion. With 19 new product launches, over 245 ANDA approvals, and strengthened partnerships, we’ve expanded our capabilities while staying committed to excellence. As we move into 2025, we’re motivated to reach even greater heights and create lasting impacts together. Here’s to a future full of possibilities!

At Strides Pharma, we are committed to driving positive societal and environmental change through our ESG initiatives. By embracing practices like our Zero Liquid Discharge facilities, we aim to minimize our ecological footprint and set new standards in sustainability. Our well-being programme Arogyadhama provides essential healthcare services in seven villages in rural Bengaluru. Additionally, our governance structure is marked by a majority of independent board members, ensuring transparency and diversity in decision-making. These endeavors embody synergICE’s commitment to upholding the trust of our partners and fostering a better world for all. Visit https://www.synergice.co to know more!